Holen Sie sich die Stockscreener-App
1.32
0.00%
0.00
Handel nachbörslich:
1.32
Schlusskurs vom Vortag:
$1.32
Offen:
$1.33
24-Stunden-Volumen:
387.55K
Relative Volume:
0.03
Marktkapitalisierung:
$52.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.34M
KGV:
-1.8938
EPS:
-0.697
Netto-Cashflow:
$-15.59M
1W Leistung:
-5.04%
1M Leistung:
-45.00%
6M Leistung:
+40.11%
1J Leistung:
-42.36%
1-Tages-Spanne:
$1.272
$1.38
1-Wochen-Bereich:
$1.272
$1.465
52-Wochen-Spanne:
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Firmenname
Heartbeam Inc
Sektor
Branche
Telefon
408-899-4443
Adresse
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.32 | 52.95M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
177.04 | 30.74B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.61 | 9.94B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.06 | 7.10B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.69B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.96 | 5.03B | 550.17M | 201.35M | 232.07M | 1.00 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-31 | Eingeleitet | Roth Capital | Buy |
| 2020-09-11 | Eingeleitet | Needham | Buy |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-08-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-07-26 | Bestätigt | Lake Street | Buy |
| 2018-04-26 | Bestätigt | The Benchmark Company | Buy |
| 2018-02-23 | Bestätigt | Dougherty & Company | Buy |
| 2017-11-08 | Bestätigt | Dougherty & Company | Buy |
| 2017-10-26 | Eingeleitet | Raymond James | Outperform |
| 2017-10-24 | Eingeleitet | SunTrust | Buy |
| 2017-08-09 | Bestätigt | Dougherty & Company | Buy |
| 2017-07-19 | Bestätigt | The Benchmark Company | Buy |
| 2017-04-11 | Bestätigt | Dougherty & Company | Buy |
| 2016-12-02 | Eingeleitet | Dougherty & Company | Buy |
| 2016-09-13 | Eingeleitet | Sidoti | Buy |
| 2016-08-03 | Bestätigt | The Benchmark Company | Buy |
| 2015-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2013-10-24 | Eingeleitet | The Benchmark Company | Buy |
| 2013-08-21 | Eingeleitet | Dougherty & Company | Buy |
Alle ansehen
Heartbeam Inc Aktie (BEAT) Neueste Nachrichten
HeartBeam Files $100 Million Mixed Shelf - marketscreener.com
Is HeartBeam Inc. Equity Warrant stock undervalued vs historical averagesWeekly Investment Recap & Real-Time Buy Signal Alerts - mfd.ru
Bryan Humbarger Named Chief Commercial Officer at HeartBeam - Medical Product Outsourcing
Aug Patterns: Can HeartBeam Inc deliver alpha2025 Price Momentum & High Return Trade Guides - baoquankhu1.vn
Market Recap: Does HeartBeam Inc Equity Warrant have pricing powerRecession Risk & Advanced Technical Signal Analysis - baoquankhu1.vn
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
Trend Review: Does HeartBeam Inc Equity Warrant have pricing power2025 Earnings Surprises & Detailed Earnings Play Alerts - baoquankhu1.vn
HeartBeam names Bryan Humbarger as CCO - Medical Buyer
US Market Wrap: How volatile is Empire State Realty OP LP Limited Partnership stockJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
HeartBeam appoints Bryan Humbarger as chief commercial officer By Investing.com - Investing.com Nigeria
HeartBeam (BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - NewMediaWire
Meme Stocks: Is CTGO on track to beat earningsTrend Reversal & Growth Focused Investment Plans - baoquankhu1.vn
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - Digital Journal
Heartbeam, Inc. Appoints Bryan Humbarger as Chief Commercial Officer, Effective January 22, 2026 - marketscreener.com
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer - 01net
HeartBeam appoints Bryan Humbarger as chief commercial officer - Investing.com
Sectors Review: Can HeartBeam Inc maintain its current growth rate2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Trend Review: Is GSR III Acquisition Corp. showing insider buyingWeekly Stock Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Activity Recap: How does Roper Technologies Inc perform in inflationary periodsMarket Trend Review & Breakout Confirmation Alerts - baoquankhu1.vn
Dow Update: Should value investors consider HeartBeam IncJuly 2025 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Recap Report: Can HeartBeam Inc Equity Warrant stock sustain revenue growthPortfolio Gains Report & Technical Pattern Recognition Alerts - Bộ Nội Vụ
Aug Gainers: Should value investors consider HeartBeam Inc2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup - TradingView — Track All Markets
What Wall Street predicts for HeartBeam Inc. Equity Warrant stock price2025 Historical Comparison & Weekly Watchlist of Top Performers - ulpravda.ru
FDA Clearance for HeartBeam (BEAT) Highlighted in Medical Device Approvals Roundup - NewMediaWire
About Us - FinancialContent
How HeartBeam Inc. stock performs in interest rate cyclesQuarterly Market Review & Fast Entry High Yield Stock Tips - Улправда
Will HeartBeam Inc. stock benefit from automationQuarterly Market Summary & Technical Entry and Exit Tips - ulpravda.ru
Is HeartBeam Inc. Equity Warrant stock safe for conservative investorsMarket Growth Review & Accurate Entry/Exit Alerts - ulpravda.ru
What sentiment indicators say about HeartBeam Inc. stock2025 Technical Overview & Short-Term Trading Alerts - Улправда
Can HeartBeam Inc. Equity Warrant stock outperform in 2025 bull marketQuarterly Trade Report & Stepwise Trade Signal Guides - Улправда
Is HeartBeam Inc. Equity Warrant stock a safe haven assetRecession Risk & Short-Term High Return Strategies - Улправда
AeroVironment Stock Surges: Military Gains Explored - StocksToTrade
Will HeartBeam Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Retail Activity & Daily Market Momentum Tracking - ulpravda.ru
FDA clearances and approvals: J&J, Abbott, Edwards Lifesciences - Modern Healthcare News
Can HeartBeam Inc. stock hit analyst price targetsGap Fill Strategies & Low Risk Capital Growth - ulpravda.ru
HeartBeam (BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - NewMediaWire
HeartBeam (NASDAQ: BEAT) to attend JP Morgan 2026 annual healthcare conference - MSN
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - TradingView — Track All Markets
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference - 01net
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - FinancialContent
Trend Recap: Is HeartBeam Inc stock recession proofMarket Trend Review & Weekly Watchlist for Consistent Profits - moha.gov.vn
How HeartBeam Inc. Equity Warrant stock reacts to global recession fearsGlobal Trade Effects & Small Budget Trading Ideas - bollywoodhelpline.com
Pharma News: What sentiment indicators say about HeartBeam Inc stockRisk Management & High Conviction Investment Ideas - moha.gov.vn
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software - MSN
Finanzdaten der Heartbeam Inc-Aktie (BEAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):